Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen H O Hoffmann
Alexander H Enk

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Dermatology (Basel, Switzerland)|December 1, 2021
Evaluation of Psoriasis Area and Severity Index Thresholds as Proxies for Systemic Inflammation on an Individual Patient LevelJochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Jochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
ScleromyxedemaJochen H O Hoffmann, Alexander H Enk
Journal of Dermatological Science|August 3, 2016
Neutrophil extracellular traps in dermatology: Caught in the NETJochen H O Hoffmann, Alexander H Enk
Frontiers in Immunology|June 28, 2019
High-Dose Intravenous Immunoglobulin in Skin Autoimmune DiseaseJochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2017
High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseasesJochen H O Hoffmann, Alexander H Enk
The Journal of Investigative Dermatology|August 11, 2020
Differential Effects of Dimethyl Fumarate and Monomethyl Fumarate on Neutrophil Granulocyte and PBMC ApoptosisJochen H O Hoffmann, Knut Schaekel, Alexander H Enk, et al.
Acta Dermato-Venereologica|October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse eventsVera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Journal of Dermatological Science|October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patientsJochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica|April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment CyclesJochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Dermatology (Basel, Switzerland)|December 1, 2021
Evaluation of Psoriasis Area and Severity Index Thresholds as Proxies for Systemic Inflammation on an Individual Patient LevelJochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
Jochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 29, 2020
ScleromyxedemaJochen H O Hoffmann, Alexander H Enk
Journal of Dermatological Science|August 3, 2016
Neutrophil extracellular traps in dermatology: Caught in the NETJochen H O Hoffmann, Alexander H Enk
Frontiers in Immunology|June 28, 2019
High-Dose Intravenous Immunoglobulin in Skin Autoimmune DiseaseJochen H O Hoffmann, Alexander H Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2017
High-dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseasesJochen H O Hoffmann, Alexander H Enk
The Journal of Investigative Dermatology|August 11, 2020
Differential Effects of Dimethyl Fumarate and Monomethyl Fumarate on Neutrophil Granulocyte and PBMC ApoptosisJochen H O Hoffmann, Knut Schaekel, Alexander H Enk, et al.
Acta Dermato-Venereologica|October 18, 2012
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse eventsVera Seidling, Jochen H O Hoffmann, Alexander H Enk, et al.
Journal of Dermatological Science|October 13, 2014
Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patientsJochen H O Hoffmann, Christian Knoop, Alexander H Enk, et al.
Acta Dermato-Venereologica|April 27, 2021
Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment CyclesJochen H O Hoffmann, Christian Knoop, Knut Schäkel, et al.
Pageof 19